Mechanisms of Immunocorrective Action of Complex Treatment Using Photodynamic, Cell and Tissue Therapy in Patients with Purulent Wounds of The Lower Extremities
E. Klimova, A. Korobov, E. A. Bychenko, L. Drozdova, E. V. Lavinskaya, T. Kordon, Y. Ivanova
{"title":"Mechanisms of Immunocorrective Action of Complex Treatment Using Photodynamic, Cell and Tissue Therapy in Patients with Purulent Wounds of The Lower Extremities","authors":"E. Klimova, A. Korobov, E. A. Bychenko, L. Drozdova, E. V. Lavinskaya, T. Kordon, Y. Ivanova","doi":"10.1109/CAOL46282.2019.9019494","DOIUrl":null,"url":null,"abstract":"It was shown that the combined use of photodynamic therapy of different wavelengths (red λ = 660 nm, green = 530 nm, blue λ = 440 nm), hematopoietic stem cells and platelet growth factor is an effective treatment for purulent-septic complications, which can be considered as a new technology for correcting afferent and efferent immunoreactivity in patients with chronic purulent wounds that are not susceptible to antibiotic therapy.","PeriodicalId":308704,"journal":{"name":"2019 IEEE 8th International Conference on Advanced Optoelectronics and Lasers (CAOL)","volume":"18 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2019-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"2019 IEEE 8th International Conference on Advanced Optoelectronics and Lasers (CAOL)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1109/CAOL46282.2019.9019494","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
It was shown that the combined use of photodynamic therapy of different wavelengths (red λ = 660 nm, green = 530 nm, blue λ = 440 nm), hematopoietic stem cells and platelet growth factor is an effective treatment for purulent-septic complications, which can be considered as a new technology for correcting afferent and efferent immunoreactivity in patients with chronic purulent wounds that are not susceptible to antibiotic therapy.